Eye Health News and Research

Latest Eye Health News and Research

Dusseldorf will be the meeting point for MEDICA and COMPAMED this week

In the coming week, from 16 to 19 November 2015, Düsseldorf will again become the central meeting point of the international health business. Then, for the first time on the new set of dates from Monday to Thursday (previously: Wednesday to Saturday), the world’s largest medical trade fair, MEDICA, and the international leading supplier specialist trade fair, COMPAMED taking place at the same time, are going to start.

9 Nov 2015

Excelitas Technologies® Corp. and Quorum Technologies Present Microscopy Systems for Optogenetics Webinar

Excelitas Technologies® Corp. and Quorum Technologies will present a webinar entitled “How Can I Build a Microscopy System for Optogenetics?” led by featured speakers Kavita Aswani, Ph.D., senior applications scientist for the Life Sciences products at Excelitas Technologies, and Ryan Geil, M.Sc., service manager at Quorum Technologies Inc. The session will be moderated by Photonics Media and takes place on Thursday, November 12 at 1:00 pm (EST).

9 Nov 2015

Touch Surgery Officially The Largest Worldwide Community Of Surgeons Practicing Surgery Virtually

Digital Surgical Simulator Touch Surgery Collaborates with Experts Surgeons at International Institutions (Stanford, Yale, Dartmouth, Vanderbilt, Imperial College London, Singapore National Eye Center & Others) to Create Simulations of Surgical Best Practices.

6 Nov 2015

Better visualization in complex reconstructive surgery with ZEISS Opmi Pentero 800 surgical microscope

The capabilities of the OPMI® PENTERO® 800 surgical microscopes from ZEISS for reconstructive surgery have been enhanced by the introduction of the INFRARED 800 module.

From Carl Zeiss Microscopy GmbH 6 Nov 2015

UCSF scientists identify eye drop chemical that may reverse cataracts

A chemical that could potentially be used in eye drops to reverse cataracts, the leading cause of blindness, has been identified by a team of scientists from UC San Francisco (UCSF), the University of Michigan (U-M), and Washington University in St. Louis (WUSTL).

6 Nov 2015

Boxing more dangerous than mixed martial arts, shows study

Mixed martial arts has a reputation for being one of the most brutal and bloody of all contact sports, but the reality is boxing poses a greater risk of serious injury, according to new research from the University of Alberta.

6 Nov 2015

Men exposed to domestic violence more worried about not being believed

Men who receive help from crisis centres are mostly satisfied with the help they get. But they fear that nobody will believe that they've been abused by a woman.

6 Nov 2015

RXi Pharmaceuticals begins Phase 1/2 clinical trial in ophthalmology

RXi Pharmaceuticals Corporation a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology today announced the initiation of a Phase 1/2 clinical trial in ophthalmology. The clinical study RXI-109-1501 will evaluate the safety and clinical activity of RXI-109 to prevent the progression of retinal scarring, a harmful component of numerous retinal diseases.

5 Nov 2015

UConn-led researchers develop simple technique for diagnosis and monitoring of sickle cell disease

A team of UConn biomedical engineers, working with colleagues from Yale, MIT, and Harvard, has developed a simple, inexpensive, and quick technique for the diagnosis and monitoring of sickle cell disease that can be used in regions where advanced medical technology and training are scarce.

5 Nov 2015

Study suggests need for specific treatment options for adolescents with onset type 2 diabetes

New results from the Treatment Options for Type 2 Diabetes in Youth study (TODAY) examined predictors of the outcomes in youth with onset type 2 diabetes (T2D) based on early characteristics at diagnosis, and suggests the need for specific criteria for adolescents that are different from those in adults.

5 Nov 2015

JEDI T-cells provide unique technology to study, visualize immune responses and immunotherapies

When it comes to fending off disease and helping prevent people from falling ill, the body's immune system -- armed with T-cells that help eliminate cancer cells, virus-infected cells and more -- is second to none. But exactly how the immune system works remains, in many ways, a mystery, as there are numerous cell types whose functions and interactions with our immune systems have not been well understood.

5 Nov 2015

Allergan signs licensing agreement with Mimetogen to develop, commercialize tavilermide for treatment of dry eye disease

Allergan plc, a leading global pharmaceutical company, today announced that its wholly owned subsidiary has entered into an exclusive licensing agreement with Mimetogen Pharmaceuticals, a clinical stage biotechnology company, to develop and commercialize tavilermide (MIM-D3), a topical formulation of a novel small molecule TrkA agonist for the treatment of dry eye disease.

4 Nov 2015

ZEISS adds INFRARED 800 to OPMI PENTERO 800 for reconstructive surgery

ZEISS is now adding INFRARED 800 to its OPMI PENTERO 800 surgical microscope for reconstructive surgery. The new enhancements are tailored to the requirements of breast reconstruction, lymph supermicrosurgery, and oral and maxillofacial surgery. Clinical specialists can benefit from the optimized package of ZEISS OPMI PENTERO 800 which provides intraoperative assessment of blood flow, higher magnification and effortless maneuverability required for complex reconstructive surgery.

4 Nov 2015

Oxford professor wins Heinrich Wieland Prize for pioneering method that helps control nerve cells with light

Gero Miesenböck was the first to insert a light-controlled on/off switch into brain cells. His pioneering method allows scientists to switch nerve cells on and off selectively and observe how the behaviour of, for example, fruit flies or mice changes as a result. In this way, researchers can learn in a step-by-step process what behaviour the studied brain circuits control and what goes awry in disease. For his method, hailed as a "breakthrough of the decade," Professor Gero Miesenböck of the University of Oxford will receive the 100,000-euro Heinrich Wieland Prize of the Boehringer Ingelheim Foundation in Munich on November 6, 2015.

4 Nov 2015

Good news for patients suffering from dry age-related macular degeneration

Scientists have good news for patients who suffer from currently untreatable dry age-related macular degeneration (dry AMD). In a new study, researchers identified a potential target for future therapies to slow the progression of the blinding condition. Published in Investigative Ophthalmology & Visual Science, the findings indicate that treatments currently used for other conditions could also work for dry AMD.

3 Nov 2015

Study identifies potential new approaches to curing parasitic diseases

A study in the Proceedings of the National Academy of Sciences shows that some forms of the single celled parasites, Trypanosoma brucei and Toxoplasma gondii behave like cancer cells.

3 Nov 2015

Experts call on U.S. and Mexican governments to reduce risk of Chagas disease

Chagas disease -- the third most common parasitic infection in the world -- affects approximately 7.5 million people, mostly in Latin America. To help reduce outbreaks of this disease in their countries, the United States and Mexican governments should implement a range of programs as well as fund research for the development of Chagas vaccines and treatments, according to a new policy brief by tropical-disease and science policy experts at Rice University's Baker Institute for Public Policy.

3 Nov 2015

Healthy food can help low-income people better control their diabetes

To determine whether healthy food could help low-income people better control their diabetes, a pilot study by UC San Francisco and Feeding America tracked nearly 700 people at food banks in California, Texas and Ohio over two years.

3 Nov 2015

Discovery offers promising alternative to current therapies for AMD and ROP

A research team led by scientists at Beth Israel Deaconess Medical Center and the University of New Mexico School of Medicine has identified a small molecule that treats animal models of aged macular degeneration (AMD) and retinopathy of prematurity (ROP) by preventing the overgrowth of blood vessels that are characteristic of these two retinal diseases.

3 Nov 2015

Charles Bonnet syndrome: an interview with Dr. Dominic ffytche

Charles Bonnet syndrome is the name we give to the visual hallucinations associated with eye disease. There are lots of different causes of visual hallucinations. Many different medical problems and medications can cause them, but, when the cause is eye disease, it's referred to as Charles Bonnet Syndrome after Charles Bonnet, who was a natural philosopher in the 18th century.

2 Nov 2015

Eye Health News and Research

Latest Eye Health News and Research

Dusseldorf will be the meeting point for MEDICA and COMPAMED this week

Excelitas Technologies® Corp. and Quorum Technologies Present Microscopy Systems for Optogenetics Webinar

Touch Surgery Officially The Largest Worldwide Community Of Surgeons Practicing Surgery Virtually

Better visualization in complex reconstructive surgery with ZEISS Opmi Pentero 800 surgical microscope

UCSF scientists identify eye drop chemical that may reverse cataracts

Boxing more dangerous than mixed martial arts, shows study

Men exposed to domestic violence more worried about not being believed

RXi Pharmaceuticals begins Phase 1/2 clinical trial in ophthalmology

UConn-led researchers develop simple technique for diagnosis and monitoring of sickle cell disease

Study suggests need for specific treatment options for adolescents with onset type 2 diabetes

JEDI T-cells provide unique technology to study, visualize immune responses and immunotherapies

Allergan signs licensing agreement with Mimetogen to develop, commercialize tavilermide for treatment of dry eye disease

ZEISS adds INFRARED 800 to OPMI PENTERO 800 for reconstructive surgery

Oxford professor wins Heinrich Wieland Prize for pioneering method that helps control nerve cells with light

Good news for patients suffering from dry age-related macular degeneration

Study identifies potential new approaches to curing parasitic diseases

Experts call on U.S. and Mexican governments to reduce risk of Chagas disease

Healthy food can help low-income people better control their diabetes

Discovery offers promising alternative to current therapies for AMD and ROP

Charles Bonnet syndrome: an interview with Dr. Dominic ffytche

Genetics & Genomics - Second Edition eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Eye Health News and Research

Latest Eye Health News and Research

Genetics & Genomics - Second Edition eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in